Google
Trusted Resources: News & Events
Latest announcements and gatherings
Doris Duke Charitable Foundation awards grant to Critical Path Institute
In a continuing effort to spur advancements in treating and curing sickle cell anemia, the Doris Duke Charitable Foundation today announced a grant to the Critical Path Institute (C-Path) to lay the groundwork for forming a collaboration of multiple stakeholder organizations to accelerate the development of therapies for the disease.
With the funding, C-Path will conduct the planning necessary to bring together scientists, clinicians and representatives from the biopharmaceutical industry, governmental regulatory agencies, academic institutions and patient advocacy organizations to identify and work collaboratively toward solving significant challenges affecting the entire research and development community.
The anticipated outcome is a consortium model engaging potential partners to work on jointly beneficial drug development tools and novel methodologies, submit them to the regulatory agencies for endorsement, and then make them available to the broader research community.
+myBinderRelated Content
-
California Institute For Regenerative Medicine Awards City Of Hope $5.74 Million For Severe Sickle Cell Disease Clin...The California Institute for Regenerativ...
-
Boston Children’s Hospital receives grant for sickle cell disease researchThe Bill and Melinda Gates Foundation aw...
-
The Sickle Cell Transplant Advocacy & Research Alliance (STAR)The Sickle Cell Transplant Advocacy &...
-
Howard Woolley, MASHoward Woolley is a philanthropist with ...
-
DDCF Awards $6 Million for Sickle Cell Disease ResearchThe Doris Duke Charitable Foundation has...
-
Investing in a Cure for Sickle Cell Disease: Lakshmanan Krishnamurti, MDhttps://www.youtube.com/watch?v=Fr5KvM4U...
-
Hope for SCDHope for SCD strives to bridge the gap b...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.